Additional Reading

  1. Boguniewicz M, et al. Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies. J Allergy Clin Immunol Pract. 2017;5:1519-1531 (www.ncbi.nlm.nih.gov/pubmed/28970084).
  2. Brunner PM, et al. Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Invest Dermatol. 2017;137:18-25 (www.ncbi.nlm.nih.gov/pubmed/27771048).
  3. DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy Asthma Proc. 2012;33:227-234 (www.ncbi.nlm.nih.gov/pubmed/22584191).
  4. Drucker AM, et al. The burden of atopic dermatitis: summary of a report for the national eczema association. J Invest Dermatol. 2017;137:26-30 (www.ncbi.nlm.nih.gov/pubmed/27616422).
  5. Egeberg A, et al. Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis. Allergy. 2017;72:783-791 (www.ncbi.nlm.nih.gov/pubmed/27864954).
  6. Eichenfield LF, et al. Current guidelines for the evaluation and management of atopic dermatitis: a comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines. J Allergy Clin Immunol. 2017;139(4S):S49-S57 (www.ncbi.nlm.nih.gov/pubmed/28390477).
  7. Eichenfield LF, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70:338-351 (www.ncbi.nlm.nih.gov/pubmed/24290431).
  8. Montes-Torres A, et al. Biological treatments in atopic dermatitis. J Clin Med. 2015;4:593-613 (www.ncbi.nlm.nih.gov/pmc/articles/PMC4470158).
  9. Paller AS, et al. Therapeutic pipeline for atopic dermatitis: end of the drought? J Allergy Clin Immunol. 2017;140:633-643 (www.ncbi.nlm.nih.gov/pubmed/28887947).
  10. Renert-Yuval Y, Guttman-Yassky E. Systemic therapies in atopic dermatitis: the pipeline. Clin Dermatol. 2017;35:387-397 (www.ncbi.nlm.nih.gov/pubmed/28709570).
  11. Silverberg JI. Healthcare utilization, patient costs, and access to care in US adults with eczema: a population-based study. JAMA Dermatol. 2015;151:743-752 (www.ncbi.nlm.nih.gov/pubmed/25738422).
  12. Thyssen JP, et al. Atopic dermatitis is associated with anxiety, depression, and suicidal ideation, but not with hospitalization or suicide. Allergy. 2018;73:214-220 (www.ncbi.nlm.nih.gov/pubmed/28632893).
  13. Wei W, et al. Discordance between physician- and patient-reported disease severity in adults with atopic dermatitis: a US cross-sectional survey. Am J Clin Dermatol. 2017;18:825-835 (www.ncbi.nlm.nih.gov/pubmed/28447213).
  14. Werfel T, et al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138:336-349 (www.ncbi.nlm.nih.gov/pubmed/27497276).
  15. Zhang A, Silverberg JI. Association of atopic dermatitis with being overweight and obese: a systematic review and metaanalysis. J Am Acad Dermatol. 2015;72:606-616.e4 (www.ncbi.nlm.nih.gov/pubmed/25773409).
Scroll to Top